A highly sensitive immunoassay, the immunomagnetic reduction, is used to measure several biomarkers for plasma that is related to Alzheimer's disease (AD). These biomarkers include Aβ-40, Aβ-42, and tau proteins. The samples are composed of four groups: healthy controls (n=66), mild cognitive impairment (MCI, n=22), very mild dementia (n=23), and mild-to-serve dementia, all due to AD (n=22).
View Article and Find Full Text PDFBackground: The key issue in preventing chronic diabetic complications is to maintain near-normoglycemia. Analytical evaluation of Bionime self-monitoring blood glucose (SMBG) Rightest GM110 was carried out in this study.
Methods: The evaluation was executed according to the Standards for Reporting Diagnostic Accuracy (STARD) and the Clinical and Laboratory Standards Institute (CLSI).